This inventor holds 4 USPTO granted patents and 2 published patent applications and 3 EPO patents. Top assignee: European Molecular Biology Laboratory. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2026
Title: Athanasios Typas: Innovator in Pharmaceutical Compositions
Introduction
Athanasios Typas is a prominent inventor based in Heidelberg, Germany. He has made significant contributions to the field of therapeutics, particularly in the development of pharmaceutical compositions aimed at preventing and treating infections. With a total of 4 patents to his name, Typas is recognized for his innovative approaches to addressing bacterial infections and their associated complications.
Latest Patents
Typas's latest patents focus on two key areas. The first patent involves pharmaceutical compositions designed for the prevention and treatment of bacterial infections and antibacterial-induced dysfunctions. This invention highlights the effectiveness of specific combinations, such as vanillin with spectinomycin, in inhibiting the growth of multi-drug resistant bacterial species. The second patent emphasizes the repurposing of pharmaceutical compounds for treating various diseases, including infectious and gastrointestinal disorders. These compounds demonstrate high specificity in targeting bacterial growth, enabling narrow-spectrum antibacterial therapies that aim to minimize side effects associated with traditional antibacterial treatments.
Career Highlights
Athanasios Typas is affiliated with the European Molecular Biology Laboratory, where he continues to advance research in the field of microbiology and therapeutics. His work is characterized by a commitment to developing innovative solutions that address pressing health challenges posed by bacterial infections.
Collaborations
Typas collaborates with esteemed colleagues, including Ana Rita Gontao Brochado and Stephan Göttig, to further enhance the impact of his research. These collaborations foster a dynamic environment for innovation and discovery in the realm of pharmaceutical sciences.
Conclusion
Athanasios Typas stands out as a key figure in the development of novel pharmaceutical compositions aimed at combating bacterial infections. His innovative work not only contributes to the scientific community but also holds promise for improving patient outcomes in the treatment of infectious diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile